ストックスクリーナーアプリを入手
1.39
13.93%
0.17
前日終値:
$1.22
開ける：
$1.23
24時間の取引高:
953.00K
Relative Volume:
4.43
時価総額：
$114.88M
収益：
-
当期純損益:
$-21.65M
株価収益率:
-4.1855
EPS:
-0.3321
ネットキャッシュフロー:
$-15.84M
1週間 パフォーマンス:
+7.75%
1か月 パフォーマンス:
+12.10%
6か月 パフォーマンス:
+5.30%
1年 パフォーマンス:
-37.39%
1日の値動き範囲:
$1.23
$1.44
1週間の範囲:
$1.14
$1.44
52週間の値動き範囲:
$0.7709
$2.63
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
CRDL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.39 | 109.92M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
150.06 | 69.30B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 47.50B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.615 | 44.47B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.19 | 18.83B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.25 | 13.43B | 2.99B | 1.21B | 1.13B | 25.06 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-28 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-26 | 開始されました | ROTH MKM | Buy |
| 2024-04-22 | 開始されました | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc (CRDL) 最新ニュース
Is Cardiol Therapeutics Inc. a good long term investmentTriple-digit profit margins - jammulinksnews.com
Cardiol Therapeutics Achieves Database Lock in ARCHER Trial for Acute Myocarditis - TipRanks
Cardiol Therapeutics announces database lock for myocarditis trial - Investing.com Australia
Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis - Yahoo Finance
What drives Cardiol Therapeutics Inc. stock priceHigh-return market picks - jammulinksnews.com
Cardiol Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - jammulinksnews.com
What analysts say about Cardiol Therapeutics Inc. stockTremendous financial leverage - Autocar Professional
(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Investment Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (NASDAQ:CRDL) Shares Down 8.5% – Here’s What Happened - Defense World
Cardiol Therapeutics shares rise 3.88% premarket after CMS achieves secondary listing on Singapore Exchange. - AInvest
Why Cardiol Therapeutics Inc. stock attracts strong analyst attentionLow Volatility High Yield Stocks - Newser
How Cardiol Therapeutics Inc. stock performs during market volatilityFree Short-Term Stock Picks - Newser
What makes Cardiol Therapeutics Inc. stock price move sharplyBreakout Momentum Alerts - Newser
(CRDL) On The My Stocks Page (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Stock Market Analysis (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (OTCMKTS:CRTPF) Trading Up 10.8% – Still a Buy? - Defense World
Cardiol Therapeutics (TSE:CRDL) Trading Up 1% – Here’s Why - Defense World
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
(CRDL) Technical Patterns and Signals (CRDL:CA) - news.stocktradersdaily.com
Cardiol Therapeutics (TSE:CRDL) Trading Up 2.1% – Here’s What Happened - Defense World
(CRDL) Financial Trading Report (CRDL:CA) - news.stocktradersdaily.com
Analysts Issue Forecasts for CRDL Q2 Earnings - Defense World
All Eyes On ARCHER: Will Cardiol's Drug For Heart Muscle Inflammation Hit The Mark? - RTTNews
Cetera Investment Advisers Takes $56,000 Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World
Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
HC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy Recommendation - Nasdaq
Cardiol Therapeutics (CRDL): HC Wainwright & Co. Initiates Coverage with a Buy Rating and $9 Price Target | CRDL Stock News - GuruFocus
H.C. Wainwright Initiates Coverage on Cardiol Therapeutics (CRDL) With Positive Outlook | CRDL Stock News - GuruFocus
(CRDL) Strategic Investment Guide (CRDL:CA) - news.stocktradersdaily.com
RAD Reports Positive Preclinical Lu177-B7H3-mAb Data - Investing News Network
Former Eli Lilly CMO Joins Cardiol’s Board, Bolstering Drug Development, Clinical Trial, and Commercial Expertise - SECFilings.com
Cardiol Therapeutics Announces AGM Results and New Board Member - TipRanks
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders | CRDL Stock News - GuruFocus
Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - Newsfile
Ex-Eli Lilly Chief Medical Officer Strengthens Cardiol Board as Critical Phase III Trial Nears Completion - Stock Titan
Cardiol Therapeutics Inc (CRDL) 財務データ
収益
当期純利益
現金流量
EPS
0.92%
0.93%
大文字化:
|
ボリューム (24 時間):